MBP and relapsing-remitting multiple sclerosis: Phenotype of tetanus toxoid (TT)- and myelin basic protein (MBP)-reactive CD3+CD8- T-cells, from untreated (UNT) and interferon (IFN)-β-treated patients with relapsing-remitting multiple sclerosis (RRMS).